Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer

Journal of the American Society of Nephrology

Volumn 25, Issue 7, 2014, Pages 1486-1495

  Huang, Chang Shuo ^a   Tang, Shye Jye ^b   Chung, Ling Yen ^a   Yu, Cheng Ping ^c   Ho, Jar Yi ^c   Cha, Tai Lung ^d   Hsieh, Chii Cheng ^e   Wang, Hsiao Hsien ^e   Sun, Guang Huan ^d   Sun, Kuang Hui ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^c Graduate Institute of Pathology and Parasitology   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GALECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; CHEMOKINE RECEPTOR; CXCR4 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MOTILITY; CLONOGENESIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL CANCER CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; DISEASE COURSE; KIDNEY TUMOR; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL; SURVIVAL RATE; TUMOR CELL CULTURE;

CHEMOKINE RECEPTOR; RENAL CARCINOMA; SURVIVAL;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; GALECTIN 1; HUMANS; KIDNEY NEOPLASMS; PROGNOSIS; RECEPTORS, CXCR4; SURVIVAL RATE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84907207296     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013070773     Document Type: Article

References (46)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012
2. Custódio S, JoaquimA, Peixoto V, Macedo JE, Faria AL, Macias E, Rego S, Araújo A: Metastatic renal cell carcinoma: The importance of immunohistochemistry in differential diagnosis. Case RepOncol 5: 30-34, 2012
3. Eisengart LJ, MacVicar GR, Yang XJ: Predictors of response to targeted therapy in renal cell carcinoma. Arch Pathol Lab Med 136: 490-495, 2012
4. Escudier B: Emerging immunotherapies for renal cell carcinoma. Ann Oncol 23[Suppl 8]: viii35-40, 2012
5. Yang RY, Rabinovich GA, Liu FT: Galectins: Structure, function and therapeutic potential. Expert Rev Mol Med 10: e17, 2008
6. Camby I, Le Mercier M, Lefranc F, Kiss R: Galectin-1: A small protein with major functions. Glycobiology 16: 137R-157R, 2006
7. van den Brûle FA, Waltregny D, Castronovo V: Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 193: 80-87, 2001
8. Szoke T, Kayser K, Baumhakel JD, Trojan I, Furak J, Tiszlavicz L, Horvath A, Szluha K, Gabius HJ, Andre S: Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 69: 167-174, 2005
9. van den Brûle F, Califice S, Garnier F, Fernandez PL, Berchuck A, Castronovo V: Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 83: 377-386, 2003
10. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R: Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61: 585-596, 2002
11. Kovács-Sólyom F, Blaskó A, Fajka-Boja R, Katona RL, Végh L, Novák J, Szebeni GJ, Krenács L, Uher F, Tubak V, Kiss R, Monostori E: Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 127: 108-118, 2010
12. Horiguchi N, Arimoto K, Mizutani A, Endo-Ichikawa Y, Nakada H, Taketani S: Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells. J Biochem 134: 869-874, 2003
13. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW: Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103: 15975-15980, 2006
14. Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y: Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20: 7486-7493, 2001
15. Mathieu V, Le Mercier M, De Neve N, Sauvage S, Gras T, Roland I, Lefranc F, Kiss R: Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J InvestDermatol 127: 2399-2410, 2007
16. Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, Sun KH: Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res 18: 4037-4047, 2012
17. Dihazi H, Müller C, Asif AR, Flad T, Elmaouhoub A, Müller GA: Whole cell profiling and identification of galectin-1 as a potential marker of renal cell carcinoma. Proteomics Clin Appl 1: 200-214, 2007
18. Masui O, White NM, DeSouza LV, Krakovska O, Matta A, Metias S, Khalil B, RomaschinAD, Honey RJ, Stewart R, Pace K, BjarnasonGA, Siu KW, YousefGM:Quantitative proteomic analysis inmetastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Mol Cell Proteomics 12: 132-144, 2013
19. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ: Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154: 1125-1135, 1999
20. Chen S, Tuttle DL, Oshier JT, Knot HJ, Streit WJ, Goodenow MM, Harrison JK: Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology 114: 565-574, 2005
21. Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL: The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 65: 10355-10362, 2005
22. Yoshida N, Ikemoto S, Narita K, Sugimura K, Wada S, Yasumoto R, Kishimoto T, Nakatani T: Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer 86: 1396-1400, 2002
23. Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE, Nakshatri H: NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638, 2003
24. Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008
25. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, CantzM, Gabius HJ: Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem276: 35917-35923, 2001
26. Suzuki O, Nozawa Y, Abe M: The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1. Int J Oncol 28: 155-160, 2006
27. Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T: Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res 59: 722-730, 2000
28. Ito K, Ralph SJ: Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence. Clin Exp Metastasis 29: 561-572, 2012
29. Ali S, Lazennec G: Chemokines: Novel targets for breast cancer metastasis. Cancer Metastasis Rev 26: 401-420, 2007
30. Wu MH, Hong HC, Hong TM, Chiang WF, Jin YT, Chen YL: Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinomametastasis by downregulatingMCP-1/CCL2 expression. Clin Cancer Res 17: 1306-1316, 2011
31. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001
32. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, Hwang ST: Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62: 7328-7334, 2002
33. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686, 2003
34. Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J: CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86: 1250-1256, 2002
35. Wang L, Chen W, Gao L, Yang Q, Liu B, Wu Z, Wang Y, Sun Y: High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. World J Surg Oncol 10: 212, 2012
36. Wang L, Wang L, Yang B, Yang Q, Qiao S, Wang Y, Sun Y: Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis. Clin Exp Metastasis 26: 1049-1054, 2009
37. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W: Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425: 307-311, 2003
38. Phillips RJ, Mestas J, Gharaee-KermaniM, BurdickMD, Sica A, Belperio JA, Keane MP, Strieter RM: Epidermal growth factor and hypoxiainduced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/ PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem280: 22473-22481, 2005
39. Isayama F, Froh M, Yin M, Conzelmann LO, Milton RJ, McKim SE, Wheeler MD: TNF alpha-induced Ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse. Hepatology 39: 721-731, 2004
40. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruïne AP: VHL and HIF signalling in renal cell carcinogenesis. J Pathol 221: 125-138, 2010
41. Zhao XY, Chen TT, Xia L, Guo M, Xu Y, Yue F, Jiang Y, Chen GQ, Zhao KW: Hypoxia inducible factor-1 mediates expression of galectin-1: The potential role in migration/invasion of colorectal cancer cells. Carcinogenesis 31: 1367-1375, 2010
42. Le Mercier M, Mathieu V, Haibe-Kains B, Bontempi G, Mijatovic T, Decaestecker C, Kiss R, Lefranc F: Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. J Neuropathol Exp Neurol 67: 456-469, 2008
43. Singh S, Srivastava SK, Bhardwaj A, Owen LB, Singh AP: CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: A novel target for therapy. Br J Cancer 103: 1671-1679, 2010
44. Jung MJ, Rho JK, Kim YM, Jung JE, Jin YB, Ko YG, Lee JS, Lee SJ, Lee JC, Park MJ: Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells. Oncogene 32: 209-221, 2013
45. Huang EY, Chen YF, Chen YM, Lin IH, Wang CC, Su WH, Chuang PC, Yang KD: A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells. Cell Death Dis 3: e251, 2012
46. Pierceall WE, Wolfe M, Suschak J, Chang H, Chen Y, Sprott KM, Kutok JL, Quan S, Weaver DT, Ward BE: Strategies for H-score normalization of preanalytical technical variables with potential utility to immunohistochemical-based biomarker quantitation in therapeutic response diagnostics. Anal Cell Pathol (Amst) 34: 159-168, 2011